Navigation Links
The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Certain Patients with Mantle Cell Lymphoma
Date:11/13/2013

of the Ohio State University, is a world-renowned CLL expert who leads an LLS-funded research team that has been instrumental in advancing ibrutinib. Other LLS-funded researchers, including Jonathan Friedberg, M.D., of University of Rochester and Jennifer Brown, M.D., Ph.D., of Dana-Farber Cancer Institute, have also played important roles in clinical trials for ibrutinib.

LLS also helped advance another BTK inhibitor, CC-292 (formerly AVL-292), which showed encouraging activity in an early trial for CLL and lymphoma patients, and is now being tested in combination therapies. LLS partnered with Avila Therapeutics through LLS's Therapy Acceleration Program, from March 2010 until Celgene Corporation acquired Avila in January 2012, bringing critical capital and commercialization expertise to the development of this promising agent.

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, multiple myeloma, and improve the quality of life of patients and their families. LLS funds livesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access o quality, affordable, coordinated care.

Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

Contact: Andrea Greif
914-821-8958
andrea.greif@lls.org


'/>"/>
SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Polaris Group Announces Treatment of First Patient in Phase 2 Study of ADI-PEG 20 in Acute Myeloid Leukemia
2. Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig
3. The Leukemia & Lymphoma Society Issues Statement Regarding the Status of Iclusig (Ponatinib)
4. The Leukemia & Lymphoma Society and the Knight Cancer Institute Launch Groundbreaking Collaboration to Improve Outcomes for Acute Myeloid Leukemia Patients
5. OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2017
6. St. Jude Childrens Research Hospital study yields new strategy against high-risk leukemia
7. The Leukemia & Lymphoma Society Co-Pay Assistance Fund Surpasses $200 Million
8. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
9. Celebrating 25 Years and Counting: Leukemia and Lymphoma Societys "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients
10. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
11. The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute to Bring Clinical Trials to Local Communities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014  Boehringer Ingelheim ... Administration (FDA) accepted for review the New Drug ... tiotropium and olodaterol delivered via the Respimat ® ... once-daily maintenance treatment of airflow obstruction in patients ... bronchitis and/or emphysema. Tiotropium + olodaterol FDC will ...
(Date:8/19/2014)... , Aug. 19, 2014 According to Kalorama ... needed to make Big Data in healthcare a reality, ... As part of the American Recovery and Reinvestment Act, ... record (EMR) projects and penalties will start applying soon ... Information, in its complete study of the EMR industry, ...
(Date:8/19/2014)... Aug. 19, 2014  Cardiva Medical, Inc. announced today ... a $16.5 million Series 3 private equity financing and ... The Company will use the proceeds of the Series ... commercial efforts for its VASCADE® Vascular Closure System in ... Investing in Series 3 private equity financing was ...
Breaking Medicine Technology:Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 2Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 3Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 4Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 5Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 6Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 7Boehringer Ingelheim Announces U.S. Filing for the Fixed-Dose Combination Tiotropium Plus Olodaterol for Patients with COPD 8Kalorama: EMR Paves the Way for Big Data 2Kalorama: EMR Paves the Way for Big Data 3Cardiva Medical, Inc. Announces Completion of the first two tranches of Series 3 Private Equity Financing and the Closing of a Senior Secured Debt Facility with GE Capital 2
(Date:8/20/2014)... (PRWEB) August 20, 2014 BuyCheapTicketsToEvents.com ... a wide selection of tickets to many events. Cheap NHL ... will begin in September. , Hockey fans are enthusiastic about ... obtain tickets for games. Now is the time to acquire ... begin in mere months. There will be a great deal ...
(Date:8/20/2014)... people grow older, they often have difficulty falling asleep ... in the morning. In individuals with Alzheimer,s disease, this ... especially pronounced, often leading to nighttime confusion and wandering. ... Israel Deaconess Medical Center (BIDMC) and the University of ... more fragmented with age. Reported online today in the ...
(Date:8/20/2014)... Mixberry Media announced today its new ... create a new source of revenue. , The innovative ... to a narration of their favorite news and articles ... Users can now multitask: read/write email, drink coffee, ... content. , Mixberry Media’s service converts news ...
(Date:8/20/2014)... August 20, 2014 Riverside Health System ... , who joined its Warsaw Medical Arts team earlier ... in Family Medicine, is accepting new patients. , Dameron, ... Medicine, completed his residency at the Mountain Area Health ... Virginia. , “I really like the rural aspect of ...
(Date:8/19/2014)... 20, 2014 As moms and dads prepare ... to return to the normal routine of dropping their little ... Kristen Yarker, MSc, RD encourages them to use the ... snack time. , Yarker explains, “Kids have small tummies, ... of giving them junk food handouts, use snack time as ...
Breaking Medicine News(10 mins):Health News:2014 NHL Preseason Tickets Are Among Top Selling Seats at Trusted Provider BuyCheapTicketsToEvents.com 2Health News:Research helps explain why elderly have trouble sleeping 2Health News:Research helps explain why elderly have trouble sleeping 3Health News:Mixberry Media, First To Offer Article Voice Narration with Integrated Audio Advertising 2Health News:Riverside Warsaw Medical Arts’ Dr. William Dameron Accepting New Patients 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3
... FirmsPHILADELPHIA, Jan. 15 /PRNewswire/ -- Michael ... Centocor, Inc., an operating company of Johnson & ... public relations consultancy, Pitch360 Incorporated ( www.pitch360inc.com ). ... issues management consultancy that leverages its vast pharmaceutical ...
... aging causes broken bones to heal slowly, or not at ... Journal of Bone and Mineral Research . The research team ... of treatments designed to "rescue" healing capability lost to aging. ... healing keeps the two sides of a fractured bone from ...
... Enterprises Ltd. ("Beeston") (OTC-BB:BESE) a resource base company ... mineral properties, announced that its Board of Directors ... of its full media campaign. MicroCap Management has ... a launch pad for Beeston,s present and future ...
... Area Treatments Twice as Fast and Improves Patient Treatment ... SLTM ) today announced the launch of ... system for faster, more comfortable body shaping, contouring and ... of traditional Thermage tips, Body Tip 16.0 cuts body ...
... WINSTON-SALEM, N.C., Jan. 15 For consumers, the Internet,offers ... vacations; however,when it comes to finding the best doctor, ... days, there are Web sites that offer ratings on,everyone ... picking,the best restaurants and hotels in town are getting ...
... Outlines Steps Taken to Reduce Expenses in Light ... Mass., Jan. 15 Cynosure, Inc. (NASDAQ: ... of a broad array of light-based aesthetic treatment ... fourth quarter ended December 31, 2008.Cynosure expects to ...
Cached Medicine News:Health News:Former Johnson & Johnson Executive Gives Big Voice to Small Companies 2Health News:Researchers detail how aging undermines bone healing 2Health News:Researchers detail how aging undermines bone healing 3Health News:Researchers detail how aging undermines bone healing 4Health News:Beeston Retains MicroCap Management, LLC as Its Lead Corporate Communications and Broker Relations Firm 2Health News:Beeston Retains MicroCap Management, LLC as Its Lead Corporate Communications and Broker Relations Firm 3Health News:Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments 2Health News:Video: Solta Medical Introduces Advanced Thermage Body Tip 16.0 for Faster Body Shaping and Contouring Treatments 3Health News:DrScore.com Says: Know Your Source When Going Online To Review Your Doctor's Rating 2Health News:DrScore.com Says: Know Your Source When Going Online To Review Your Doctor's Rating 3Health News:Cynosure Provides Preliminary Financial Results for the Fourth Quarter of 2008 2Health News:Cynosure Provides Preliminary Financial Results for the Fourth Quarter of 2008 3Health News:Cynosure Provides Preliminary Financial Results for the Fourth Quarter of 2008 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: